Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




ELISA Reader Features Modern Light Source, Small Footprint

By LabMedica International staff writers
Posted on 09 Oct 2012
Performance features of a new microplate absorbance reader include optimized optics, a modern light source of principally unlimited lifetime, and a multiple-filter capacity that enables a broad range of applications.

The Apollo 11 ELISA Absorbance Reader provided by Berthold Technologies (Bad Wildbad, Germany), a company specializing in bioanalytical instruments for diagnostics and research, is a product of long-time, continuous optimization of ELISA reader technology and in particular introduces its new unlimited life-time LED light source technology. More...
The instrument also has the capacity to install up to six filters, enabling a variety of applications in one system, including DNA quantification, protein quantification, various enzyme activity assays including beta-Galactosidase and for immunoassay/ELISA - alkaline phosphatase and horseradish peroxidase. For extraordinary accuracy and precision (providing dependable measurement repeatability and traceable, comparable results), the Apollo 11 reader has an unusually large dynamic range of 0 to 3.7 OD, sophisticated optics, a robust mechanical design, and an integrated function that performs autocheck and autocalibration of the optics and electronics before every measurement.

An additional valuable feature is the PhotoRead software for showing on a single screen: data, commands, settings, and displays needed during operation. The easy-to-use self-explaining one-view PhotoRead software also allows initiation of measurements within seconds. Microplate shaking can be adjusted from a choice of 4 amplitudes and 4 speeds. Also notable is that the unit’s small footprint size (210 x 281 x 160 mm) saves valuable laboratory space.

Related Links:

Berthold Technologies


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.